The composition of follow - on formulas (FUF)-- marketed for babies over 6 months — and universally agreed by all health agencies to be unnecessary — will have identical compositional
requirements as infant formulas for newborn babies.
Not exact matches
That this House is concerned that the provisions of the
Infant Formula and Follow - on Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to c
Infant Formula and Follow - on Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to
Formula and Follow - on
Formula Regulations 2007 are disrespected in the UK, as evidenced by the current promotion for Nestlé SMA infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to
Formula Regulations 2007 are disrespected in the UK,
as evidenced by the current promotion for Nestlé SMA
infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to c
infant formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to
formula by Tesco in breach of Article 23 of that regulation, the near identical labelling of
infant and follow - on formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to c
infant and follow - on
formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to
formula to make them cross-promotional in breach of Article 19 of that regulation, the widespread advertising of
infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to c
infant formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those requirements, such as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to
formula brand names and logos in breach of Article 21 of that regulation and the use of idealising text and images on labels in breach of Article 17 of that regulation; therefore rejects the Department of Health's proposals to decriminalise certain of those
requirements, such
as labelling provisions in planned draft legislative proposals, related to EU Regulation 609/2015 which will replace these 2007 regulations; and stresses that any move to a system of Improvement Notices must have the purpose of speeding up compliance and be backed by prosecutions rather than giving companies who have flouted the law for many years additional time to comply.
The press release does not report on how many mothers buying SMA
infant formula are aware that their babies have «protein intake in excess of
requirements», according to the latest information from Nestlé, but it is likely to be higher than 80 %
as Nestlé has only announced this to health workers.
Nestlé exacerbates the cross-promotional impact of its advertising
as its labels do not comply with the labelling
requirements, which state: «the specific terms «
infant formula» and «follow - on
formula» should be clearly featured on the packaging, in a font size no smaller than the brand name.»
Though there are minor differences such
as whey ratios, taste and texture, all baby
formulas must meet FDA
requirements under the
Infant Formula Act.
«No unique role of young - child
formulae with respect to the provision of critical nutrients in the diet of
infants and young children living in Europe can be identified, so that they can not be considered
as a necessity to satisfy the nutritional
requirements of young children when compared with other foods that may be included in the normal diet of young children (such
as breast milk,
infant formulae, follow - on
formulae and cow's milk).»
Because of this, it is important to continue to provide breast milk or
infant formula during the gradual transition to solid foods
as they will still contribute substantially towards your
infant's total nutrient
requirements.
(Tesco was attempting to clear stocks of this
infant formula as Nestlé introduced a new
formula, informing health workers that babies fed on the current formulation received «protein in excess of
requirements».
The
Infant Formula and Follow - on Formula Regulation is in force, but will apply from 22nd February 2020, except in respect of infant formula and follow on formula manufactured from protein hydrolysates, to which it shall apply from 22nd February 2021: COMMISSION DELEGATED REGULATION (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow - on formula and as regards requirements on information relating to infant and young child f
Infant Formula and Follow - on Formula Regulation is in force, but will apply from 22nd February 2020, except in respect of infant formula and follow on formula manufactured from protein hydrolysates, to which it shall apply from 22nd February 2021: COMMISSION DELEGATED REGULATION (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow - on formula and as regards requirements on information relating to infant and young child
Formula and Follow - on
Formula Regulation is in force, but will apply from 22nd February 2020, except in respect of infant formula and follow on formula manufactured from protein hydrolysates, to which it shall apply from 22nd February 2021: COMMISSION DELEGATED REGULATION (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow - on formula and as regards requirements on information relating to infant and young child
Formula Regulation is in force, but will apply from 22nd February 2020, except in respect of
infant formula and follow on formula manufactured from protein hydrolysates, to which it shall apply from 22nd February 2021: COMMISSION DELEGATED REGULATION (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow - on formula and as regards requirements on information relating to infant and young child f
infant formula and follow on formula manufactured from protein hydrolysates, to which it shall apply from 22nd February 2021: COMMISSION DELEGATED REGULATION (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow - on formula and as regards requirements on information relating to infant and young child
formula and follow on
formula manufactured from protein hydrolysates, to which it shall apply from 22nd February 2021: COMMISSION DELEGATED REGULATION (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow - on formula and as regards requirements on information relating to infant and young child
formula manufactured from protein hydrolysates, to which it shall apply from 22nd February 2021: COMMISSION DELEGATED REGULATION (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council
as regards the specific compositional and information
requirements for
infant formula and follow - on formula and as regards requirements on information relating to infant and young child f
infant formula and follow - on formula and as regards requirements on information relating to infant and young child
formula and follow - on
formula and as regards requirements on information relating to infant and young child
formula and
as regards
requirements on information relating to
infant and young child f
infant and young child feeding